Clinical Data of Patients
| Gleason score | Pretherapy type | Implanted seeds | No./location of migrated seeds detected by… | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. | Day* | Age (y) | PSA | n | Dose (MBq) | Radiography | Scintigraphy | ||
| 1 | 1 | 78 | 21.3 | 3 + 4 | — | 94 | 1,438.2 | N | N |
| 2 | 1 | 82 | 13.95 | 3 + 3 | Hormone therapy | 69 | 1,055.7 | N | B1 |
| 3 | 1 | 64 | 6.4 | 3 + 3 | Hormone therapy | 86 | 1,315.8 | N | N |
| 4 | 29 | 71 | 12.7 | 3 + 3 | Hormone therapy | 59 | 902.7 | N | N |
| 5 | 1 | 72 | 8.87 | 3 + 3 | — | 84 | 1,285.2 | B3 | B3 |
| 6 | 1 | 81 | 23.18 | 3 + 4 | Hormone therapy | 74 | 1,132.2 | N | L1 |
| 7 | 1 | 73 | 4.7 | 3 + 3 | — | 81 | 1,239.3 | N | N |
| 8 | 1 | 66 | 9.92 | 6 | Hormone therapy | 81 | 1,239.3 | N | P1 |
| 9 | 1 | 73 | 9.74 | 3 + 4 | Hormone therapy | 70 | 1,071.0 | N | P1, B1 |
| 10 | 1 | 62 | 4.8 | 3 + 4 | Hormone therapy | 68 | 1,040.4 | P2 | P3 |
| 11 | 1 | 73 | 11 | 3 + 4 | Hormone therapy | 57 | 872.1 | N | P1 |
| 12 | 8 | 68 | 12.9 | 6 | Hormone therapy | 46 | 703.8 | P1 | P3 |
| 13 | 1 | 60 | 6.3 | 3 + 3 | — | 80 | 1,224.0 | N | P2 |
| 14 | 1 | 67 | 15.2 | 3 + 3 | — | 74 | 1,132.2 | P1 | P1 |
| 15 | 1 | 75 | 19.39 | 3 + 3 | External radiation therapy | 74 | 1,132.2 | N | N |
| 16 | 1 | 72 | 4.65 | 4 + 3 | Hormone therapy | 85 | 1,300.5 | N | B2 |
| Total no. of seeds | 1,182 | 7 | 20 | ||||||
↵* Examination day after brachytherapy.
PSA = prostate-specific antigen level at time of diagnosis (ng/mL); B1 = 1 in bladder; B2 = 2 in bladder; B3 = 3 in bladder; L1 = 1 in lungs; N = no migration; P1 = 1 in pelvis; P2 = 2 in pelvis.